Korangy F - Search Results

1

Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma.

Duffy AG, Ulahannan SV, Makorova-Rusher O, Rahma O, Wedemeyer H, Pratt D, Davis JL, Hughes MS, Heller T, ElGindi M, Uppala A, Korangy F, Kleiner DE, Figg WD, Venzon D, Steinberg SM, Venkatesan AM, Krishnasamy V, Abi-Jaoudeh N, Levy E, Wood BJ, Greten TF. Duffy AG, et al. Among authors: korangy f. J Hepatol. 2017 Mar;66(3):545-551. doi: 10.1016/j.jhep.2016.10.029. Epub 2016 Nov 2. J Hepatol. 2017. PMID: 27816492 Free PMC article. Clinical Trial.

2

Peptide-beta2-microglobulin-MHC fusion molecules bind antigen-specific T cells and can be used for multivalent MHC-Ig complexes.

Greten TF, Korangy F, Neumann G, Wedemeyer H, Schlote K, Heller A, Scheffer S, Pardoll DM, Garbe AI, Schneck JP, Manns MP. Greten TF, et al. Among authors: korangy f. J Immunol Methods. 2002 Dec 20;271(1-2):125-35. doi: 10.1016/s0022-1759(02)00346-0. J Immunol Methods. 2002. PMID: 12445736

3

Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo.

Scheffer SR, Nave H, Korangy F, Schlote K, Pabst R, Jaffee EM, Manns MP, Greten TF. Scheffer SR, et al. Among authors: korangy f. Int J Cancer. 2003 Jan 10;103(2):205-11. doi: 10.1002/ijc.10777. Int J Cancer. 2003. PMID: 12455034 Free article.

4

Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma.

Korangy F, Ormandy LA, Bleck JS, Klempnauer J, Wilkens L, Manns MP, Greten TF. Korangy F, et al. Clin Cancer Res. 2004 Jul 1;10(13):4332-41. doi: 10.1158/1078-0432.CCR-04-0181. Clin Cancer Res. 2004. PMID: 15240519

5

Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma.

Ormandy LA, Hillemann T, Wedemeyer H, Manns MP, Greten TF, Korangy F. Ormandy LA, et al. Among authors: korangy f. Cancer Res. 2005 Mar 15;65(6):2457-64. doi: 10.1158/0008-5472.CAN-04-3232. Cancer Res. 2005. PMID: 15781662

6

Genetically induced pancreatic adenocarcinoma is highly immunogenic and causes spontaneous tumor-specific immune responses.

Garbe AI, Vermeer B, Gamrekelashvili J, von Wasielewski R, Greten FR, Westendorf AM, Buer J, Schmid RM, Manns MP, Korangy F, Greten TF. Garbe AI, et al. Among authors: korangy f. Cancer Res. 2006 Jan 1;66(1):508-16. doi: 10.1158/0008-5472.CAN-05-2383. Cancer Res. 2006. PMID: 16397267

7

Direct ex vivo analysis of dendritic cells in patients with hepatocellular carcinoma.

Ormandy LA, Farber A, Cantz T, Petrykowska S, Wedemeyer H, Horning M, Lehner F, Manns MP, Korangy F, Greten TF. Ormandy LA, et al. Among authors: korangy f. World J Gastroenterol. 2006 May 28;12(20):3275-82. doi: 10.3748/wjg.v12.i20.3275. World J Gastroenterol. 2006. PMID: 16718852 Free PMC article.

8

Immunotherapy of hepatocellular carcinoma.

Greten TF, Manns MP, Korangy F. Greten TF, et al. Among authors: korangy f. J Hepatol. 2006 Dec;45(6):868-78. doi: 10.1016/j.jhep.2006.09.004. Epub 2006 Sep 29. J Hepatol. 2006. PMID: 17046096 Review. No abstract available.

9

Necrotic tumor cell death in vivo impairs tumor-specific immune responses.

Gamrekelashvili J, Krüger C, von Wasielewski R, Hoffmann M, Huster KM, Busch DH, Manns MP, Korangy F, Greten TF. Gamrekelashvili J, et al. Among authors: korangy f. J Immunol. 2007 Feb 1;178(3):1573-80. doi: 10.4049/jimmunol.178.3.1573. J Immunol. 2007. PMID: 17237406

10

Immune based therapies in cancer.

Krüger C, Greten TF, Korangy F. Krüger C, et al. Among authors: korangy f. Histol Histopathol. 2007 Jun;22(6):687-96. doi: 10.14670/HH-22.687. Histol Histopathol. 2007. PMID: 17357098 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

76 results

Search Page